Similar documents
49619, H. influenzae ATCC49247, C. jejuni ATCC 33252, C. fetus ATCC15296, B. fragilis ATCC 25285, C. soldellii ATCC9714, P. rnagnus ATCC lin (ABPC), e

Key words: Candida, fungemia, antifungal activity, micafungin, fluconazole-resistant

Table 1. Antimicrobial drugs using for MIC

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr non-albicans 4 non-albicans C. glabrata, C. parapsilosis, C. tropicalis, C. krusei 4 C. guil


CHEMOTHERAPY FEB. 1994

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

988 CHEMOTHERAPY NOV. 1971

日本化学療法学会雑誌第53巻第S-3号




Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote


Fig. 1 Chemical structure of DL-8280


VOL.47 NO.5 Table 1. Susceptibility distribution of Ĉ- lactams against clinical isolates of MRSA MRSA: rnethicillin- resistant Staphylococcus aureus


Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

VOL.48 NO.7 lase negative staphylococci, Escherichia coli, Klebsiella spp., Citrobacter freundii, Enterobacter spp., indole-positive Proteus, Serratia

日本化学療法学会雑誌第50巻新薬特集号

ひとくちメモ/山口英世先生

Some Investigations of Urinary Candidiasis Chujiro YAMAMOTO, M. D., Mitsushi MIZUTANI, M. D. and Tokuro SATO, M. D. From the Department of Urology, Ni


Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

Key words:group D streptococci,classification,enterococcal infections, Antibiotic susceptibility,vancomycin

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

感染症学雑誌第80巻第6号

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,

Study on Application of the cos a Method to Neutron Stress Measurement Toshihiko SASAKI*3 and Yukio HIROSE Department of Materials Science and Enginee

THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium xerosis 10Š, Corynebacterium pseudodiphtheriticum 10Š, Corynebacterium

1272 CHEMOTHERAPY MAR. 1975


技術論文 Daptomycin の Etest 法による MIC 測定における 精度管理の重要性および問題点 中島 英恵 1) 1) 長野市民病院臨床検査科 長野県長野市富竹 要 旨 ダプトマイシン DAP 非感性株を含む Staphylococcus aureus

CHEMOTHERAPY

名称未設定-1

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

Fig.1 Chemical structure of BAY o 9867

perature was about 2.5 Ž higher than that of the control irrespective of wind speed. With increasing wind speeds of more than 1m/s, the leaf temperatu

udc-2.dvi

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F


CHEMOTHERAPY FEB Table 1 Background of volunteers

VOL. 34 S-2 CHEMOTH8RAPY 913

dihydrostreptomycin(sm), sulfanilamide(sa), kanamycin(km), paromomycin(prm), fradiomycin(frm), ampicillin(apc), cephaloridine (CER), nalidixic acid(na

Key words: Surfactant, Tween, Legionella

VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St

23 A Comparison of Flick and Ring Document Scrolling in Touch-based Mobile Phones

日本職業・災害医学会会誌第51巻第1号

Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Ta

06_学術_関節単純X線画像における_1c_梅木様.indd

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330)

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

Key Words: Klebsiella pneumoniae, CEP-AIS, MIC, "MBC", MIC of drugs in combination

Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis

VOL.42 S-1

Table1MIC of BAY o 9867 against standard strains

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc


Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

VOL. 23 NO. 3 CHEMOTHERAPY 1379 Table 1 Susceptibility of clinical isolated strains to Tobramycin


Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

国土技術政策総合研究所 研究資料

07_学術.indd


THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr NTT NTT

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent


CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

CHEMOTHERAPY JUNE 1986



CHEMOTHERAPY MAY. 1988

-95-


原 著 S 1, S S S / 60 7 / / S S OTC 7


epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

Motivation and Purpose There is no definition about whether seatbelt anchorage should be fixed or not. We tested the same test conditions except for t

A A




CHEMOTHERAPY SEPT Amphotericin B (AMPH-B), flucytosine (5- SDA PDA Procedure for disk method 1. Prepare agar plates containing two-fold dilution

CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

process of understanding everyday language is similar, finally as far as word production is concerned, individual variations seem to be greater at an

2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11

320 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -,* -,/ (,**1) 8 * ** *** * ** *** E#ect of Superheated Steam Treatment on the Preservation an

VOL. 43 NO. 4

日本化学療法学会雑誌第56巻第3号

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega


Transcription:

Key words: yeast, Etest(R), microdilution method, MIC

Table 1 MICs of quality control strains The data shown are the range of MIC performed in triplicate

Table 2 Renge of MICs, MIC50s and MIC90s for 81 species of yeast

Table 3 Comparison of E test MICs with FP panel MICs

Table 4 Test of significance to MICs by FP panel and E test *: <0.05 significant **: <0.01 significant

6) Kitchen VS, Savage M, Harris FRW: Candida albicans resistance in AIDS. J Infect 1991; 22: 204-205. 7) Smith D, Boag F, Midgley F, Gazzard B: Fluconazole resistant Candida in AIDS. J Infect 10) AB BIODISK. 1997. Etest technical guide No. 4: Antifungal susceptibility testing of yeasts. AB BIODISK, Solna, Sweden. 11) National Committee for Clinical Laboratory Stan- dards: Perfomance standards for antimicrobial disk susceptibility tests sixthedition; Approved sylvania, 1997. 12) National Committee for Clinical Laboratory Standards: standard. NCCLS Document M2-A5. Wayne, Pen- 2) Anaissie E: Opportunistic mycoses in the immunocompromised Reference method for broth dilution anti- host : Experience at a cancer center and review. C Infect Dis 1992; 14 (Suppl. fungal susceptibility testing of yeasts; Standard M27-A 1997. Approved 1): S43-53. 13) Eldere JV, Joosten L, Verhaeghe A, Surmont I: Fluconazole and amphotericin B antifungal susceptibility testing by national committee for clini- cal laboratory standards broth macrodilution 4) Fox R, Neal KR, Leen CLS, Ellis ME, Mandal method compared with Etest and semiautomated BK: Fluconazole resistant Candida in AIDS. J Infect 1991; 22: 201-204. broth microdilution test. J Clin Microbiol Apr 1996; 842-847. 14) Colombo AL, Barchiesi F, McGough DA, Fother- gill AW, Rinaldi MG : Evaluation of the Etest system versus a microtitre broth method for antifungal susceptibility testing of yeasts against fluconaole and itraconazole. J Antimicro Chemother 1995; 36: 93-100. 15) Colombo AL, Barchiesi F, McGough DA, Rinaldi 1991; 23: 345-346. MG: Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J Clin Microbiol 1995; 33: 535-540. 16) Pfaller MA, Messer SA, Karlsson A, Bolmstrom A: Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J Clin Microbiol 1998; 2586-2589.

Evaluation of a New Method for Antifungal Drugs Susceptibility Testing to Yeasts Shinobu ISHIGAKI1), Sayoko KAWAKAMI1), Yasuo ONO1)2)&Yukihisa MIYAZAWA1) Department of Central Laboratory, 2)Department of Microbiology and Immunology, Teikyo School of Medicine We compared the Etest(R) with a broth microdilution method (FP panel(r)), performed according to the National Committee for modified Clinical Laboratory Standards (NCCLS) document M27-P guidelines, for determining the MICs of 81 clinical isolates of yeasts (7 Candida albicans, 8 Candida glabrata, 10 Candida parapsilosis, 6 Pichia anomala, 10 Candida tropicalis, 4 Candida guilliermondii, 4 Candida krusei, 6 Trichosporon cutaneum, 5 Candida ciferrii, 3 Candida famata, 4 Candida norvegensis, 2 Rhodotorula rubra, 3 Candida lusitaniae, 2 Candida curvata, 1 Candida inconspicua, 1 Candida intermedia, 1 Candida colliculosa, 1 Cryptococcus spp, 1 Tricosporon capitatum, 1 Pichia ohmeri, 1 Saccharomyces cerevisiae). The Etest(R) results for 6 ATCC standard strains correlated well with reference MICs except those of flucytosine (5-FC) for C. krusei, which tended to be 1 to 2 log2 dilution higher than the MIC range determined by NCCLS guidelines. However, the best agreement between the results for clinical isolates was seen with 5-FC (100% agreement [Within }2 log2 dilutions] between the results of the two methods). There was a 91.4% agreement between the results of the two methods with amphotericin B (Etest(R) MICs tended to be 1 to 2 log2 dilution lower than those of the FP panel). The Etest(R) results with litraconazole for clinical isolates except C. tropicalis were similar to MICs of the FP panel(r) (Etest(R) for C. tropicalis showed 1 to 2 log2 dilution lower than FP panel(r)). Also, the Etest(R) results with fluconazole for clinical isolates except C. tropicalis were similar of 1 log2 dilution higher than MICs of the FP panel(r) (Etest(R) for C. tropicalis showed more than 2 log2 dilution lower thas FP panel(r)). These results showed a good level of overall agreement between the Etest(R) method and the broth microdilution test (FP panel(r)). Since the Etest(R) is a less laborintensive and much simpler method, it appears to be a useful procedure for testing the susceptibility of yeasts to antifungal agents.